The Procter & Gamble Company

The Procter & Gamble Company is an American multinational consumer goods company that manufactures and sells a diversified portfolio of branded daily-use products across five segments — Fabric & Home Care, Baby Feminine & Family Care, Beauty, Health Care, and Grooming — generating $84.3 billion in revenue in fiscal 2025. Its products, which include Tide, Pampers, Gillette, Pantene, and Crest, are sold in approximately 180 countries and used by an estimated 5 billion consumers globally.

This is a story about a 188-year-old company trying to prove it can still grow in a world that looks increasingly hostile to the branded consumer packaged goods model. P&G enters fiscal 2027 carrying a premium valuation, a portfolio of category-leading brands, and an integrated strategy built around product superiority — but also facing a consumer stretched by cumulative inflation, an energy-driven cost shock from the Middle East conflict, and a retail and media landscape that fragments further every quarter. The file turns on a single question: whether the innovation flywheel can produce enough organic growth to justify the multiple at a time when the forces that have powered P&G's margin recovery — commodity tailwinds and aggressive pricing — are reversing.

The bull case is already partly priced. The stock trades at roughly 21.5 times trailing earnings, a level that implies the market believes P&G can deliver dependable mid-single-digit EPS growth. The debates that matter are about the composition of that growth — how much comes from volume versus price, how much margin headroom remains, and whether the interventions management is making across the portfolio are gaining enough mass to move the aggregate numbers. P&G has earned the benefit of the doubt over a very long history. The question is whether the next chapter looks more like the steady compounding of the last decade or the more difficult periods that preceded it.